Centro Médico Viamonte SRL - CABA, Buenos Aires
Somos un centro con más de 18 años de experiencia en protocolos de investigación y participamos activamente en el desarrollo de nuevos tratamientos que mejoran la calidad de vida de las personas, sobre todo en enfermedades crónicas como la diabetes y sus problemas oculares asociados. Ofrecemos atención en diferentes especialidades, aumentando la disponibilidad de medicación y tratamientos, basándonos en principios éticos con un equipo profesional y multidisciplinario.Av. Córdoba 2019, CABA, Buenos Aires
Select an option
I am a doctor
I am a sponsor
Specializations
Diabetes
Oftalmología
Cardiología
Hígado graso
Nefropatia diabética
Obesidad
Covid-19
Our team
Medical staff
Diego Aizenberg
Alejandro Coussio
Fiorella Argento
Leandro Ianni
Silvina Bilicich
Martin Suarez
Guadalupe Ruiz
Jose Luis Taborda
Mariano Fallet
Open studies
Obesity
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity - Eli Lilly and CompanySee more
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity - TRIUMPH-5 - Eli Lilly and CompanySee more
Diabetes
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity - Eli Lilly and CompanySee more
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) - Eli Lilly and CompanySee more
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) - TRANSCEND-T2D-3 - Eli Lilly and CompanySee more
Cardiovascular disease
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
